Literature DB >> 11454850

Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study.

N P Gall, M T Kearney, A Zaman, S O'Nunain, K A Fox, A Flapan, J Nolan.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11454850      PMCID： PMC1729852          DOI： 10.1136/heart.86.2.219a

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  26 in total

1.  National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?

Authors:  C J Knight
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

Review 2.  Epidemiology, aetiology, and prognosis of heart failure.

Authors:  J J McMurray; S Stewart
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

3.  The diagnosis of heart failure.

Authors:  A D Struthers
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

4.  Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests.

Authors:  O W Nielsen; J F Hansen; J Hilden; C T Larsen; J Svanegaard
Journal:  BMJ       Date:  2000-01-22

5.  Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries.

Authors:  C Berry; C A Hamilton; M J Brosnan; F G Magill; G A Berg; J J McMurray; A F Dominiczak
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

6.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.

Authors:  T J Guzik; N E West; E Black; D McDonald; C Ratnatunga; R Pillai; K M Channon
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

Review 7.  The taxanes: an update.

Authors:  J Crown; M O'Leary
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

8.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

9.  Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.

Authors:  P S Sanmuganathan; P Ghahramani; P R Jackson; E J Wallis; L E Ramsay
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

10.  Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries.

Authors:  C Huraux; T Makita; S Kurz; K Yamaguchi; F Szlam; M M Tarpey; J N Wilcox; D G Harrison; J H Levy
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690
View more
  1 in total

Review 1.  Prevalence and incidence of arrhythmias and sudden death in heart failure.

Authors:  John G F Cleland; Sudipta Chattopadhyay; Aleem Khand; Timothy Houghton; Gerald C Kaye
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.